Insider · CIK 0001424620

Thomas John C

Reports to the SEC for 5 companies · ALPHARETTA, GA

sec.gov

Transactions

Companies

Filings

CIK

0001424620

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-16	DWTXDogwood Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+16.8K sh	—	—	16,800
2025-06-27	DWTXDogwood Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+2,362 sh	—	—	2,362
2025-06-18	DWTXDogwood Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+210 sh	—	—	210
2025-06-18	DWTXDogwood Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+210 sh	—	—	420
2024-02-26	DWTXDogwood Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+4,167 sh	—	—	4,167
2023-06-15	DWTXDogwood Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+5,250 sh	—	—	5,250
2022-06-23	DWTXDogwood Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+5,250 sh	—	—	5,250
2022-01-04	DWTXDogwood Therapeutics, Inc.P Purchase	Director	PPurchase	+1,000 sh	$5.65	+$5,650	1,000
2021-06-22	DWTXDogwood Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+7,875 sh	—	—	7,875
2021-02-23	IBRXImmunityBio, Inc.G Gift	Former Director	GGift	−5,000 sh	—	—	202,477
2020-12-10	IBRXImmunityBio, Inc.S Sale	Former Director	SSale	−42.6K sh	$10.83	−$461K	207,477
2020-08-19	IBRXImmunityBio, Inc.S Sale	Former Director	SSale	−20K sh	$9.19	−$184K	250,069
2020-08-13	IBRXImmunityBio, Inc.S Sale	Former Director	SSale	−20K sh	$9.49	−$190K	290,069
2020-08-13	IBRXImmunityBio, Inc.S Sale	Former Director	SSale	−20K sh	$9.34	−$187K	270,069
2020-08-11	IBRXImmunityBio, Inc.S Sale	Former Director	SSale	−19.8K sh	$10.35	−$205K	310,279
2020-08-11	IBRXImmunityBio, Inc.S Sale	Former Director	SSale	−210 sh	$10.55	−$2,215.5	310,069
2020-06-10	IBRXImmunityBio, Inc. · Stock Option (right to buy)A Award	Former Director	AAward	+100K sh	—	—	100,000
2019-12-16	IBRXImmunityBio, Inc.S Sale	Former Director	SSale	−10K sh	$3.14	−$31.4K	330,069
2019-12-13	IBRXImmunityBio, Inc.S Sale	Former Director	SSale	−10K sh	$2.48	−$24.8K	350,069
2019-12-13	IBRXImmunityBio, Inc.S Sale	Former Director	SSale	−10K sh	$2.98	−$29.8K	340,069
2019-12-12	IBRXImmunityBio, Inc.S Sale	Former Director	SSale	−10K sh	$1.99	−$19.9K	360,069
2019-09-09	IBRXImmunityBio, Inc.S Sale	Former Director	SSale	−14K sh	$1.24	−$17.3K	370,069
2019-09-06	IBRXImmunityBio, Inc.S Sale	Former Director	SSale	−7,080 sh	$1.24	−$8,779.2	384,025
2019-09-05	IBRXImmunityBio, Inc.S Sale	Former Director	SSale	−2,964 sh	$1.25	−$3,705	391,105
2019-06-06	IBRXImmunityBio, Inc.A Award	Former Director	AAward	+92.6K sh	—	—	394,069
2018-08-09	NOVELION THERAPEUTICS INC.Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2018-06-07	IBRXImmunityBio, Inc.A Award	Former Director	AAward	+27.3K sh	—	—	301,477
2018-01-02	IBRXImmunityBio, Inc.G Gift	Former Director	GGift	−4,500 sh	—	—	274,155
2017-12-15	Innoveren Scientific, Inc.P Purchase	Director	PPurchase	−6,000 sh	$0.70	−$4,200	115,960
2017-12-15	Innoveren Scientific, Inc.P Purchase	Director	PPurchase	+6,000 sh	$0.70	+$4,200	115,960
2017-10-30	Innoveren Scientific, Inc.A Award	Director	AAward	+12.8K sh	$1.17	+$15K	109,960
2017-06-20	IBRXImmunityBio, Inc.S Sale	Former Director	SSale	−10K sh	$7.43	−$74.3K	308,655
2017-06-20	IBRXImmunityBio, Inc.S Sale	Former Director	SSale	−20K sh	$7.44	−$149K	288,655
2017-06-20	IBRXImmunityBio, Inc.S Sale	Former Director	SSale	−10K sh	$7.54	−$75.4K	278,655
2017-06-09	IBRXImmunityBio, Inc.A Award	Former Director	AAward	+23.8K sh	—	—	318,655
2017-05-30	IBRXImmunityBio, Inc.G Gift	Former Director	GGift	−12.5K sh	—	—	294,902
2017-01-12	Innoveren Scientific, Inc.A Award	Director	AAward	+21.7K sh	$1.38	+$30K	97,139
2016-12-22	NOVELION THERAPEUTICS INC.Stock Option (Right to Buy)A Award	Director	AAward	+9,600 sh	—	—	9,600
2016-11-25	IBRXImmunityBio, Inc.S Sale	Former Director	SSale	−6,168 sh	$7.50	−$46.3K	309,621
2016-11-23	IBRXImmunityBio, Inc.S Sale	Former Director	SSale	−7,000 sh	$7.50	−$52.5K	315,789
2016-11-23	IBRXImmunityBio, Inc.S Sale	Former Director	SSale	−7,719 sh	$7.50	−$57.9K	315,070
2016-11-22	IBRXImmunityBio, Inc.S Sale	Former Director	SSale	−13K sh	$7.50	−$97.5K	322,789
2016-08-29	IBRXImmunityBio, Inc.G Gift	Former Director	GGift	−1,500 sh	—	—	307,402
2016-06-17	NOVELION THERAPEUTICS INC.Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2016-06-17	NOVELION THERAPEUTICS INC.Phantom StockA Award	Director	AAward	+6,400 sh	—	—	28,400
2016-05-26	IBRXImmunityBio, Inc.M Exercise/Conversion	Former Director	MExercise/Conversion	+278K sh	$0.22	+$60K	335,789
2016-05-26	IBRXImmunityBio, Inc. · Stock Option (right to buy)M Exercise/Conversion	Former Director	MExercise/Conversion	−278K sh	—	—	0
2016-03-01	IBRXImmunityBio, Inc.G Gift	Former Director	GGift	−16K sh	—	—	58,064
2015-08-31	IBRXImmunityBio, Inc.G Gift	Former Director	GGift	−2,775 sh	—	—	74,064
2015-08-25	IBRXImmunityBio, Inc.G Gift	Former Director	GGift	−15.7K sh	—	—	76,839

Recent filings

Accepted (ET)
Jun 174
Thomas John C0001424620-26-000002
SEC(opens sec.gov)
Jul 14
Thomas John C0001415889-25-018645
SEC(opens sec.gov)
Jun 234
Thomas John C0001415889-25-017934
SEC(opens sec.gov)
Feb 284
Thomas John C0001415889-24-005684
SEC(opens sec.gov)
Jun 204
Thomas John C0001415889-23-009989
SEC(opens sec.gov)
Jun 304
Thomas John C0001415889-22-007087
SEC(opens sec.gov)
Jan 285
Thomas John C0001326110-22-000004
SEC(opens sec.gov)
Jan 44
Thomas John C0001415889-22-000165
SEC(opens sec.gov)
Jun 234
Thomas John C0001415889-21-003152
SEC(opens sec.gov)
Dec 114
Thomas John C0001209191-20-062936
SEC(opens sec.gov)
Aug 214
Thomas John C0001209191-20-047941
SEC(opens sec.gov)
Aug 134
Thomas John C0001209191-20-046677
SEC(opens sec.gov)
Jun 114
Thomas John C0001209191-20-036040
SEC(opens sec.gov)
Dec 164
Thomas John C0001209191-19-060767
SEC(opens sec.gov)

Companies

Address

C/O DOGWOOD THERAPEUTICS, INC. 44 MILTON AVENUE

ALPHARETTA, GA, 30009